Suppr超能文献

加泰罗尼亚肌萎缩侧索硬化症患者群体中铜/锌超氧化物歧化酶基因的突变分析:所有散发性肌萎缩侧索硬化症病例都应进行超氧化物歧化酶1(SOD1)筛查吗?

Mutational analysis of the Cu/Zn superoxide dismutase gene in a Catalan ALS population: should all sporadic ALS cases also be screened for SOD1?

作者信息

Gamez Josep, Corbera-Bellalta Marc, Nogales Gisela, Raguer Nuria, García-Arumí Elena, Badia-Canto Mercè, Lladó-Carbó E, Alvarez-Sabín José

机构信息

Department of Neurology, Hospital Universitari Vall d'Hebron, UAB, Passeig Vall d'Hebron, 119-135, 08035 Barcelona, Spain.

出版信息

J Neurol Sci. 2006 Aug 15;247(1):21-8. doi: 10.1016/j.jns.2006.03.006. Epub 2006 May 3.

Abstract

BACKGROUND

SOD1 gene mutations are the most common identified cause of ALS, accounting for approximately 20% of familial ALS cases and around 4% of sporadic ALS cases. However, the prevalence of SOD1 varies in different ethnic groups. No previous epidemiological studies have been carried out in Catalonia.

OBJECTIVE

To determine the prevalence of SOD1 gene mutations in a Catalan ALS population, and to analyze the genotype-phenotype relationship.

MATERIALS AND METHODS

30 different FALS pedigrees and 94 sporadic ALS patients were screened for SOD1 mutations using direct sequence analysis.

RESULTS

Five of the 30 FALS pedigrees (16.6%) carried a SOD1 mutant. The mutations identified in this group were G37R, D76V, S105L, I112M and N139H. Four SOD1 mutants (4.25%) were found in the sporadic ALS group (SALS). The overall frequency (FALS plus SALS) of SOD1 mutations in our series was 6.45%. In the SALS group, D90A was identified in a patient presenting the typical Scandinavian phenotype. A 53-year-old woman with no family history of ALS carried the N139H mutation. Two unrelated sporadic ALS cases carried the A140A SOD1 mutant.

CONCLUSIONS

The prevalence of the SOD1 mutation in FALS in Catalonia is similar to levels in other Mediterranean countries, but lower than those in reports studying the Belgian, Japanese, and Scottish populations. The prevalence of the SOD1 mutation was 4.25% in patients with no family history of ALS. These results may have significant repercussions on genetic counseling, and screening for the SOD1 mutation in sporadic ALS cases must therefore be considered.

摘要

背景

超氧化物歧化酶1(SOD1)基因突变是已确定的肌萎缩侧索硬化症(ALS)最常见病因,约占家族性ALS病例的20%,散发性ALS病例的4%左右。然而,SOD1的患病率在不同种族群体中有所不同。加泰罗尼亚此前尚未开展过流行病学研究。

目的

确定加泰罗尼亚ALS人群中SOD1基因突变的患病率,并分析基因型与表型的关系。

材料与方法

采用直接测序分析法对30个不同的家族性ALS家系和94例散发性ALS患者进行SOD1突变筛查。

结果

30个家族性ALS家系中有5个(16.6%)携带SOD1突变。该组中鉴定出的突变有G37R、D76V、S105L、I112M和N139H。在散发性ALS组(SALS)中发现4个SOD1突变体(4.25%)。我们系列研究中SOD1突变的总体频率(家族性ALS加散发性ALS)为6.45%。在SALS组中,一名表现出典型斯堪的纳维亚表型的患者中鉴定出D90A。一名无ALS家族史的53岁女性携带N139H突变。两例无关的散发性ALS病例携带A140A SOD1突变体。

结论

加泰罗尼亚家族性ALS中SOD1突变的患病率与其他地中海国家的水平相似,但低于对比利时、日本和苏格兰人群的研究报告中的患病率。无ALS家族史患者中SOD1突变的患病率为4.25%。这些结果可能对遗传咨询产生重大影响,因此必须考虑对散发性ALS病例进行SOD1突变筛查。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验